Drug Type Fc fusion protein |
Synonyms Dimeric glycoprotein VI-Fc, GPVI-Fc, Revacept + [1] |
Target |
Action inhibitors |
Mechanism GPVI inhibitors(Platelet membrane glycoprotein VI inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Coronary Artery Disease | Phase 2 | Germany | 20 Nov 2017 | |
Amaurosis Fugax | Phase 2 | Germany | 08 Mar 2013 | |
Amaurosis Fugax | Phase 2 | United Kingdom | 08 Mar 2013 | |
Atherosclerosis | Phase 2 | Germany | 08 Mar 2013 | |
Atherosclerosis | Phase 2 | United Kingdom | 08 Mar 2013 | |
Carotid Stenosis | Phase 2 | Germany | 08 Mar 2013 | |
Carotid Stenosis | Phase 2 | United Kingdom | 08 Mar 2013 | |
Ischemic Attack, Transient | Phase 2 | Germany | 08 Mar 2013 | |
Ischemic Attack, Transient | Phase 2 | United Kingdom | 08 Mar 2013 | |
Stroke | Phase 2 | Germany | 08 Mar 2013 |